Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6603246.pdf
Reference17 articles.
1. Auvinen A, Maattanen L, Stenman UH, Tamela T, Ranniko S, Aro J, Juusela H, Hakama M (2002) Lead-time in prostate cancer screening (Finland). Cancer Causes Control 13(3): 279–285
2. Ciatto S, Gervasi G, Bonardi R, Frullini P, Zendron P, Lombardi C, Crocetti E, Zappa M (2005) Determining overdiagnosis by screening with DRE/TRUS or PSA (Florence pilot studies, 1991–1994). Eur J Cancer 41(3): 411–415
3. Draisma G, Boer R, Otto SJ, van der Gruijsen IW, Damhuis RA, Schroden FH, de Koning HJ (2003) Lead times and overdetection due to prostate –specific antigen screening estimates from the European Randomized Study of Screening for prostate cancer. J Natl cancer Inst 95(12): 868–878
4. Duffy SW, Hill C, Esteve J (eds) (2001) Quantitative Methods for the Evaluation of Cancer Screening. Arnold: London
5. Emiliozzi P, Scarpone P, DePaula F (2004) The incidence of prostate cancer in men with prostate specific antigen greater than 4.0 ng ml−1: a randomized study of 6 vs 12 core transperineal prostate biopsy. J Urol 171: 197–199
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Data-driven overdiagnosis definitions: A scoping review;Journal of Biomedical Informatics;2023-11
2. Cancer Screening, Incidental Detection, and Overdiagnosis;Clinical Chemistry;2023-09-27
3. Deceptive measures of progress in the NHS long-term plan for cancer: case-based vs. population-based measures;British Journal of Cancer;2023-06-17
4. Assessing overdiagnosis of fecal immunological test screening for colorectal cancer with a digital twin approach;npj Digital Medicine;2023-02-10
5. The mapping of cancer incidence and mortality trends in the UK from 1980–2013 reveals a potential for overdiagnosis;Scientific Reports;2018-10-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3